In a recent Clinical Research News article, Anju’s Vice President and General Manager of the Data Division, Barbara Argibay Gonzalez, shared her thought leadership on leveraging advanced technologies for clinical trial success.
Drug development is a lengthy, expensive, and complex process, so the stakes and the risks are high. Fortunately, sponsors, CROs, and innovators can now take advantage of clinical business intelligence technologies like TA Scan that can ensure the success of a clinical trial. From jump-starting early planning, facilitating patient recruitment and retention, streamlining feasibility analysis, leveraging Big Data and AI, to ensuring a diverse patient population, Barbara has great recommendations for innovative solutions. Read the full Clinical Research News article here.
Barbara Argibay Gonzalez
Barbara Argibay Gonzalez, Vice President and General Manager of the Data Division at Anju Software, oversees TA Scan, a comprehensive, web-based clinical and commercial intelligence solution that aggregates, connects, and analyzes global clinical trial data and other data sources into a single, intuitive database. She is also responsible for Data Science’s product development, engineering, operations, and business development. Barbara brings over 15 years of experience in data and clinical research, and holds a PhD in Medicine, as well as MS and BS degrees in Physics from the University of Santiago de Compostela, Spain. She can be reached at Barbara.Argibay@AnjuSoftware.com.